| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | actin filament binding | 1.08e-05 | 227 | 122 | 9 | GO:0051015 | |
| GeneOntologyMolecularFunction | spectrin binding | 5.34e-05 | 34 | 122 | 4 | GO:0030507 | |
| GeneOntologyMolecularFunction | double-stranded RNA binding | 1.16e-04 | 78 | 122 | 5 | GO:0003725 | |
| GeneOntologyCellularComponent | intercalated disc | 5.04e-05 | 68 | 123 | 5 | GO:0014704 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 2.35e-04 | 94 | 123 | 5 | GO:0044291 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 3.24e-04 | 290 | 123 | 8 | GO:0043292 | |
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 32285610 | ||
| Pubmed | MYBBP1A SHROOM3 ERBIN SNAP29 THADA USO1 EXD2 SEC24B PDS5A DGCR8 ATP1A1 CAMSAP1 MGA DYNC1H1 | 7.75e-07 | 777 | 124 | 14 | 35844135 | |
| Pubmed | Analysis of the role of membrane polarity in polycystic kidney disease of transgenic SBM mice. | 1.53e-06 | 7 | 124 | 3 | 7495297 | |
| Pubmed | TRAPPC11 MYBBP1A DDX59 AGPAT5 RETREG2 ORC3 ZNF571 USO1 COMMD9 SULF1 MITF GEMIN4 YTHDF3 | 3.00e-06 | 750 | 124 | 13 | 11230166 | |
| Pubmed | MYBBP1A ZNF148 SPTAN1 MBNL1 ZNF521 XRCC1 ERBIN SDAD1 EMSY CCNA2 SEC24B MITF PDS5A ZNF420 ATP1A1 MGA DYNC1H1 YTHDF3 | 3.30e-06 | 1429 | 124 | 18 | 35140242 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 3.98e-06 | 341 | 124 | 9 | 32971831 | |
| Pubmed | A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. | 4.32e-06 | 118 | 124 | 6 | 27377895 | |
| Pubmed | MYBBP1A ZNF148 SPTAN1 ACTN1 ERBIN EMSY SNAP29 MRTFB SEC24B MGA DYNC1H1 | 4.66e-06 | 549 | 124 | 11 | 38280479 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | TMEM94 RAPGEF1 PLEKHA6 ERBIN SLC9A1 SH2D4A SLC15A1 EXD2 FLRT3 ATP1A1 CAMSAP1 | 6.52e-06 | 569 | 124 | 11 | 30639242 |
| Pubmed | 7.15e-06 | 11 | 124 | 3 | 30410445 | ||
| Pubmed | 9.51e-06 | 12 | 124 | 3 | 21705333 | ||
| Pubmed | Amelogenesis imperfecta in a new animal model--a mutation in chromosome 5 (human 4q21). | 9.51e-06 | 12 | 124 | 3 | 15271968 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | PDS5B ANK1 MYO7A DOCK11 TBC1D2B SDAD1 IFIH1 SNX14 XIRP2 ATP1A1 | 1.24e-05 | 497 | 124 | 10 | 36774506 |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 23882135 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 31757807 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 11027149 | ||
| Pubmed | Growth and muscle defects in mice lacking adult myosin heavy chain genes. | 1.26e-05 | 2 | 124 | 2 | 9382868 | |
| Pubmed | Defects in the MITF(mi/mi) apical surface are associated with a failure of outer segment elongation. | 1.26e-05 | 2 | 124 | 2 | 11520113 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 11150240 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 18094063 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 34070827 | ||
| Pubmed | Structural determinants for the ouabain-stimulated increase in Na-K ATPase activity. | 1.26e-05 | 2 | 124 | 2 | 24566089 | |
| Pubmed | Expression and synthesis of the Na,K-ATPase beta 2 subunit in human retinal pigment epithelium. | 1.26e-05 | 2 | 124 | 2 | 8918259 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 35986423 | ||
| Pubmed | A direct link between MITF, innate immunity, and hair graying. | 1.26e-05 | 2 | 124 | 2 | 29723194 | |
| Pubmed | Phosphorylation of ankyrin down-regulates its cooperative interaction with spectrin and protein 3. | 1.26e-05 | 2 | 124 | 2 | 2970468 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 7711835 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 22212557 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 32503129 | ||
| Pubmed | Skeletal muscle adaptations in response to voluntary wheel running in myosin heavy chain null mice. | 1.26e-05 | 2 | 124 | 2 | 11744674 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 20427472 | ||
| Pubmed | Endothelin-2 deficiency causes growth retardation, hypothermia, and emphysema in mice. | 1.41e-05 | 41 | 124 | 4 | 23676500 | |
| Pubmed | 1.55e-05 | 87 | 124 | 5 | 20801516 | ||
| Pubmed | DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration. | 1.56e-05 | 14 | 124 | 3 | 21297615 | |
| Pubmed | 1.56e-05 | 14 | 124 | 3 | 24938781 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | PDS5B AGPAT5 FAM221A SPTAN1 BIRC2 SDAD1 SNAP29 CDK5R1 SEC24B ATP1A1 MERTK CAMSAP1 YTHDF3 | 2.68e-05 | 922 | 124 | 13 | 27609421 |
| Pubmed | 2.85e-05 | 437 | 124 | 9 | 20562859 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 3.23e-05 | 444 | 124 | 9 | 34795231 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | PDS5B MYBBP1A SLC35E1 SLIT2 THADA USO1 EXD2 SEC24B GEMIN4 PDS5A ATP1A1 ZW10 DYNC1H1 | 3.35e-05 | 942 | 124 | 13 | 31073040 |
| Pubmed | 3.52e-05 | 449 | 124 | 9 | 31732153 | ||
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 3.77e-05 | 3 | 124 | 2 | 26059207 | |
| Pubmed | FHL2 switches MITF from activator to repressor of Erbin expression during cardiac hypertrophy. | 3.77e-05 | 3 | 124 | 2 | 26025865 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 36515178 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 9159180 | ||
| Pubmed | Ankyrin facilitates intracellular trafficking of alpha1-Na+-K+-ATPase in polarized cells. | 3.77e-05 | 3 | 124 | 2 | 18768923 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 28343969 | ||
| Pubmed | A synaptic F-actin network controls otoferlin-dependent exocytosis in auditory inner hair cells. | 3.77e-05 | 3 | 124 | 2 | 26568308 | |
| Pubmed | Desulfation of Heparan Sulfate by Sulf1 and Sulf2 Is Required for Corticospinal Tract Formation. | 3.77e-05 | 3 | 124 | 2 | 29062064 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 30029086 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 27314452 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 10567402 | ||
| Pubmed | MBNL1 drives dynamic transitions between fibroblasts and myofibroblasts in cardiac wound healing. | 3.77e-05 | 3 | 124 | 2 | 35176223 | |
| Pubmed | Pds5B is required for cohesion establishment and Aurora B accumulation at centromeres. | 3.77e-05 | 3 | 124 | 2 | 24141881 | |
| Pubmed | Niche-Mediated Integrin Signaling Supports Steady-State Hematopoiesis in the Spleen. | 3.77e-05 | 3 | 124 | 2 | 33637617 | |
| Pubmed | Mapping the binding sites of human erythrocyte ankyrin for the anion exchanger and spectrin. | 3.77e-05 | 3 | 124 | 2 | 2141335 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 25370455 | ||
| Pubmed | CX3CL1 (fractalkine) protein expression in normal and degenerating mouse retina: in vivo studies. | 3.77e-05 | 3 | 124 | 2 | 25191897 | |
| Pubmed | Ankyrin-independent membrane protein-binding sites for brain and erythrocyte spectrin. | 3.77e-05 | 3 | 124 | 2 | 2971657 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 27814376 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 11193188 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | PDS5B MYH4 MYBBP1A EBF3 SGK1 XRCC1 CMYA5 SDAD1 SARS2 SH2D4A USO1 GEMIN4 PDS5A ZW10 DYNC1H1 | 5.49e-05 | 1284 | 124 | 15 | 17353931 |
| Pubmed | Different mechanisms of CDK5 and CDK2 activation as revealed by CDK5/p25 and CDK2/cyclin A dynamics. | 7.53e-05 | 4 | 124 | 2 | 16407256 | |
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 1985022 | ||
| Pubmed | Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. | 7.53e-05 | 4 | 124 | 2 | 11029314 | |
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 18925574 | ||
| Pubmed | Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling. | 7.53e-05 | 4 | 124 | 2 | 18417546 | |
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 12547197 | ||
| Pubmed | Subunit isoform selectivity in assembly of Na,K-ATPase α-β heterodimers. | 7.53e-05 | 4 | 124 | 2 | 22696220 | |
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 10388558 | ||
| Pubmed | TRIP13 localizes to synapsed chromosomes and functions as a dosage-sensitive regulator of meiosis. | 7.53e-05 | 4 | 124 | 2 | 39207914 | |
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 11023856 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 29217591 | ||
| Pubmed | The role of mouse mutants in the identification of human hereditary hearing loss genes. | 7.53e-05 | 4 | 124 | 2 | 10320095 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | MYBBP1A MYO7A EBF3 MBNL1 SLC35E1 ACTN1 SNAP29 POSTN SLIT2 THADA SH2D4A ARHGAP44 SEC24B ZW10 DYNC1H1 | 7.55e-05 | 1321 | 124 | 15 | 27173435 |
| Pubmed | SHROOM3 ORC3 SLC35E1 ACTN1 XRCC1 ERBIN SDAD1 EMSY SLC9A1 MRTFB EXD2 FBXO28 SEC24B GEMIN4 PDS5A DGCR8 | 8.71e-05 | 1497 | 124 | 16 | 31527615 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | PDS5B MYBBP1A MIS18BP1 AGPAT5 ORC3 SLC35E1 ACTN1 SDAD1 USO1 GEMIN4 PDS5A ZNF420 ATP1A1 MGA | 1.03e-04 | 1203 | 124 | 14 | 29180619 |
| Pubmed | 1.10e-04 | 131 | 124 | 5 | 28634551 | ||
| Pubmed | 1.11e-04 | 407 | 124 | 8 | 12693553 | ||
| Pubmed | 1.25e-04 | 5 | 124 | 2 | 7961179 | ||
| Pubmed | Thyrotoxic periodic paralysis and polymorphisms of sodium-potassium ATPase genes. | 1.25e-04 | 5 | 124 | 2 | 16430714 | |
| Pubmed | 1.25e-04 | 5 | 124 | 2 | 21406181 | ||
| Pubmed | 1.25e-04 | 5 | 124 | 2 | 12223541 | ||
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 1.25e-04 | 5 | 124 | 2 | 3829126 | |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 1.25e-04 | 5 | 124 | 2 | 12919077 | |
| Pubmed | Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections. | 1.25e-04 | 5 | 124 | 2 | 30737693 | |
| Pubmed | 1.25e-04 | 5 | 124 | 2 | 6196357 | ||
| Pubmed | Cyclin-dependent kinase 5 mediates pleiotrophin-induced endothelial cell migration. | 1.25e-04 | 5 | 124 | 2 | 29651006 | |
| Pubmed | Reversible oxidative modification: a key mechanism of Na+-K+ pump regulation. | 1.25e-04 | 5 | 124 | 2 | 19542013 | |
| Pubmed | 1.51e-04 | 222 | 124 | 6 | 37071664 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.62e-04 | 430 | 124 | 8 | 35044719 | |
| Pubmed | PDS5B ZNF148 EBF3 ORC3 MBNL1 ACTN1 XRCC1 EMSY PDS5A SMS ATP1A1 ZW10 DYNC1H1 | 1.63e-04 | 1103 | 124 | 13 | 34189442 | |
| Pubmed | 1.85e-04 | 31 | 124 | 3 | 33777788 | ||
| Pubmed | Pax6-dependent Shroom3 expression regulates apical constriction during lens placode invagination. | 1.87e-04 | 6 | 124 | 2 | 20081189 | |
| Pubmed | 1.87e-04 | 6 | 124 | 2 | 1728586 | ||
| Pubmed | 1.87e-04 | 6 | 124 | 2 | 15837422 | ||
| Pubmed | 1.87e-04 | 6 | 124 | 2 | 20417199 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 1.87e-04 | 6 | 124 | 2 | 10077619 | |
| Pubmed | MRTF-SRF signaling is required for seeding of HSC/Ps in bone marrow during development. | 1.87e-04 | 6 | 124 | 2 | 25573994 | |
| Pubmed | Epigenetic regulation of brain region-specific microglia clearance activity. | 1.87e-04 | 6 | 124 | 2 | 30038282 | |
| Pubmed | 1.87e-04 | 6 | 124 | 2 | 12397396 | ||
| Interaction | CTNNB1 interactions | MYBBP1A SHROOM3 MYO7A SGK1 SPTAN1 USP29 ACTN1 PLEKHA6 ERBIN CCNA2 SLIT2 CDK5R1 USO1 PTPRZ1 SEC24B MITF ATP1A1 DYNC1H1 PICK1 | 7.93e-06 | 1009 | 120 | 19 | int:CTNNB1 |
| Cytoband | 4q21.1 | 3.12e-06 | 37 | 124 | 4 | 4q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q21 | 4.83e-04 | 133 | 124 | 4 | chr4q21 | |
| GeneFamily | ATPase Na+/K+ transporting subunits | 4.00e-04 | 7 | 80 | 2 | 1208 | |
| GeneFamily | Fibronectin type III domain containing | 7.18e-04 | 160 | 80 | 5 | 555 | |
| GeneFamily | COMM domain containing | 8.50e-04 | 10 | 80 | 2 | 979 | |
| GeneFamily | Myosin heavy chains | 1.96e-03 | 15 | 80 | 2 | 1098 | |
| GeneFamily | T-boxes | 2.83e-03 | 18 | 80 | 2 | 766 | |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_UP | 2.62e-06 | 184 | 123 | 8 | M9988 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.16e-08 | 180 | 124 | 8 | 8f774dcacc1626e4e6492f1eb927b0ed56fbe686 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.14e-07 | 179 | 124 | 7 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.69e-07 | 181 | 124 | 7 | bd7e9437839bca543ca5945df43d6525e6a312a8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.28e-07 | 183 | 124 | 7 | d2074b13b4831ec18c81273d9a1ff673c3f6a16d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.90e-07 | 185 | 124 | 7 | f4ac62009c0ad3346e71b809e17727303c4df153 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.23e-07 | 186 | 124 | 7 | 948815663c212c4311329d503b5991cbbbff9808 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.57e-07 | 187 | 124 | 7 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.91e-07 | 188 | 124 | 7 | 72cbfe9dc0583dbeafa6cb0945fa370d0c808284 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-06 | 189 | 124 | 7 | 78cf414b98bcb19deb934409acddaad1cd51b67f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.06e-06 | 190 | 124 | 7 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | PSB-critical-LOC-Epithelial-Basal|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.45e-06 | 199 | 124 | 7 | 2add64c3e4cb6384ec381f34c3f1f77e13e3f27c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.50e-06 | 200 | 124 | 7 | 3cbb01039d1e7635ec4dcdf0223587f7ea3c7b34 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.50e-06 | 200 | 124 | 7 | 4a426ef88376d8bb2b9dc50aa06e7b9fc50ecc9c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.50e-06 | 200 | 124 | 7 | 1276bfa911fddada4235e12e3081baa53164574b | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.50e-06 | 200 | 124 | 7 | 97a010a1b6d551239cf6ea5a43319fb413ff180e | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.50e-06 | 200 | 124 | 7 | 8ccf2dbbe34b26fbf2bbef1e64b4ae636edd6672 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.50e-06 | 200 | 124 | 7 | fbeee1c16ac0a7fe28d90491c8b079f21ce80bdc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.50e-06 | 200 | 124 | 7 | c6eda342ea0cb37d71d89dbb8d11e819e0745172 | |
| ToppCell | 367C-Myeloid-Monocyte-CD16+_Monocyte|Monocyte / Donor, Lineage, Cell class and subclass (all cells) | 8.80e-06 | 172 | 124 | 6 | fb8ab2576b5c38db63573a3bf46b8d9d634c4999 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-05 | 177 | 124 | 6 | 91706bd0d4dda8d98843fb00b898d5aca4d66b64 | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 179 | 124 | 6 | 804aa3899585fc7e662eff9f6d41f48655f16dd6 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.14e-05 | 180 | 124 | 6 | 0b1d370db64862fe1c7ea0ffaf06d03ec82e6e70 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 181 | 124 | 6 | 1db1eb7d330a7e5090994007ae287e11f0a74450 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 181 | 124 | 6 | 06174ce9240c9261c0f51a1b0d875335d60722e5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-05 | 182 | 124 | 6 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-05 | 183 | 124 | 6 | 121791ef84e7ce377ed6f5b7953af8865e04958e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-05 | 183 | 124 | 6 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.29e-05 | 184 | 124 | 6 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.37e-05 | 186 | 124 | 6 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.46e-05 | 188 | 124 | 6 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.55e-05 | 190 | 124 | 6 | d19bc44310c53726e2f5f6a2bd377bbbf1d1983f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.55e-05 | 190 | 124 | 6 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.55e-05 | 190 | 124 | 6 | 39ab890104b4264c68a968f920f4ccd84f0bc681 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.55e-05 | 190 | 124 | 6 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.55e-05 | 190 | 124 | 6 | 0acf1d5da68db449d8c9e70519a236ce825f9d11 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.55e-05 | 190 | 124 | 6 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.64e-05 | 192 | 124 | 6 | 67d6230e32d446dcb12047fae2c3f1faa80dd720 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.64e-05 | 192 | 124 | 6 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.69e-05 | 193 | 124 | 6 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.69e-05 | 193 | 124 | 6 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 1.74e-05 | 194 | 124 | 6 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.74e-05 | 194 | 124 | 6 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.90e-05 | 197 | 124 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.90e-05 | 197 | 124 | 6 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | Epithelial_cells-Basal_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.95e-05 | 198 | 124 | 6 | 4235005c49fc2b29ad3a0ee6b608f0109d04f775 | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.01e-05 | 199 | 124 | 6 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.01e-05 | 199 | 124 | 6 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.01e-05 | 199 | 124 | 6 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.01e-05 | 199 | 124 | 6 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-MEPE-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.07e-05 | 200 | 124 | 6 | d4161fcbbe47236aac4a077c0994887e765b0b47 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-MEPE|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.07e-05 | 200 | 124 | 6 | 0d0c69758370d3c44ffe6640e332b6118fc5ce58 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.07e-05 | 200 | 124 | 6 | c65e6336725856c4b5f6aeba1cf86a23ec815d34 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-MEPE--L4-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.07e-05 | 200 | 124 | 6 | c546fa80876640bd57a5252df611977009bef9e8 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW12-Stem_cells|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 2.07e-05 | 200 | 124 | 6 | 4a57d6ba1531ce4e263daccd5de487977e6a1fdd | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW12-Stem_cells-Stem_cells|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 2.07e-05 | 200 | 124 | 6 | b706526b9c3485889a31253a1ffd017ad3f3fddc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.07e-05 | 200 | 124 | 6 | 117a25b3b9cdbc2e198381350a8362bee25e82e7 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.07e-05 | 200 | 124 | 6 | d459e51507bf26865e6e7e04411379ec82a3edf8 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Sema3e_Kank4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.82e-05 | 135 | 124 | 5 | 54b2aaf8d322e01a3ff6099c2422d68ecccf96b4 | |
| ToppCell | Pericytes-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 6.30e-05 | 150 | 124 | 5 | dbc202bd6db4fb5c8b2abd1200e074a2a9e63a59 | |
| ToppCell | PND07-28-samps-Mesenchymal-Pericyte-pericyte_F|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.30e-05 | 150 | 124 | 5 | 2d0d6dc07dcfe28e3d7694c52d15d17dae2fd47b | |
| ToppCell | PND07-28-samps-Mesenchymal-Pericyte|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.30e-05 | 150 | 124 | 5 | 5b111ec11a642d63fafa7e1422e36f81a2776531 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_A2|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.30e-05 | 150 | 124 | 5 | 6bdf9df586f348641a25a445e83a41e47e7f347e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-05 | 153 | 124 | 5 | 79c4f4ccdc8249c8461075c73491bc3b2d13344a | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.36e-05 | 155 | 124 | 5 | 0fd66c623cb433ceaa893bc21ba2e3b394faaf70 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.59e-05 | 156 | 124 | 5 | 0f54d62c0fc08bbdd5ac743b2d5d748c3d1e6ef9 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma|TCGA-Bladder / Sample_Type by Project: Shred V9 | 8.06e-05 | 158 | 124 | 5 | dc559503bab3ec1b9ea54ef2e896d1be33e5344c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.55e-05 | 160 | 124 | 5 | 14dfa519e68bab4bce890ddb66fa7763f18d9f19 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.55e-05 | 160 | 124 | 5 | 839bbdfd4e4c7b48260c8bfb7670378634405e1d | |
| ToppCell | Mild-Lymphoid-Plasma|Mild / Condition, Lineage, Cell class and cell subclass | 8.55e-05 | 160 | 124 | 5 | 7fdb849f5caf5a127a2582326215e11f8eb4fa0e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.55e-05 | 160 | 124 | 5 | 5b7789d4668ed7732babedc32d812233b430e0bd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.55e-05 | 160 | 124 | 5 | bba1486faaad5299e10f4fe17c6d149c28dc2560 | |
| ToppCell | Mild-Lymphoid-Plasma-|Mild / Condition, Lineage, Cell class and cell subclass | 8.55e-05 | 160 | 124 | 5 | aa79848913910c01249d6cacf4ed53ec0e4f5c3d | |
| ToppCell | Adult-Immune-B_cell-D231|Adult / Lineage, Cell type, age group and donor | 9.33e-05 | 163 | 124 | 5 | 4f5821299b265663c7d0352b28285f56e1988841 | |
| ToppCell | facs-Marrow-KLS-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.33e-05 | 163 | 124 | 5 | b83a35c4426d66b5734a98fa6c72b345fe462030 | |
| ToppCell | facs-Marrow-KLS-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.33e-05 | 163 | 124 | 5 | c20ca9b6b4170ebcb0e66eef3e5d8ebff22b1a91 | |
| ToppCell | Basal_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 9.61e-05 | 164 | 124 | 5 | 85487a303194f5244956ec1ca2d1758d38117f41 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.02e-04 | 166 | 124 | 5 | 37f5264491d75af690dd94eea2cf7763f42b2a2a | |
| ToppCell | mild_COVID-19-HSPC|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.08e-04 | 168 | 124 | 5 | 90b33962adb77d8326dee403712118398b4d1315 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 169 | 124 | 5 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | mild_COVID-19-HSPC|World / disease group, cell group and cell class (v2) | 1.14e-04 | 170 | 124 | 5 | 85c476e0bc496445e868a88849960598d97bdea2 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-04 | 171 | 124 | 5 | 3d26ef58fe5231373d7df9ac79d225546918cf82 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.30e-04 | 175 | 124 | 5 | 9d797888edb39fd12fd9cfc698a42b7bed19a5b5 | |
| ToppCell | T_cells-Tph_and_Tfh|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.34e-04 | 176 | 124 | 5 | 56c055488e34605d32562571a2fee621b47c9441 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-04 | 176 | 124 | 5 | 75412d58438d71c49a6096bb2ef12b7f349653d8 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-04 | 176 | 124 | 5 | 682a1dfcc507ec540f5fadf08e872533ea9f0291 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-04 | 176 | 124 | 5 | 45c6983ab671b0f306e7390320bd84f848e474cc | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.37e-04 | 177 | 124 | 5 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.41e-04 | 178 | 124 | 5 | 6ad46b0720298bcb927fd53468bb4ea0c199ad35 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 179 | 124 | 5 | 479116ac65488c60104a053530830763ec1f95b2 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 179 | 124 | 5 | 1dfc0cb8b369aef35c59f3d4c52603dc9f3728c1 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.45e-04 | 179 | 124 | 5 | f5bb4d3a27d56698473219970e764084096cc582 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 179 | 124 | 5 | 69a1b3b05c921de6343ffe6ad998aa2b804312a7 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 179 | 124 | 5 | 7078022e60faa86444f2a2c6eb9f767cc66b5cfa | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.45e-04 | 179 | 124 | 5 | fa03ec3cc0132f977b4cb28e7b23789732375183 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 179 | 124 | 5 | d4a975d8ffa5e77fb5c0ec05bf9c8f843c77ce07 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.52e-04 | 181 | 124 | 5 | af92b8b7f455210dab502ef6964f3a0162180759 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.52e-04 | 181 | 124 | 5 | 274c0b768925cd5804483303f8c5ebd17a534c41 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 181 | 124 | 5 | 0b1e7335648823b1d83bdfa878ccd44efe7bba9a | |
| ToppCell | HSPCs-Erythroblasts|World / Lineage and Cell class | 1.52e-04 | 181 | 124 | 5 | ce26f1accc8f69b7bc4b929073e975c887566c6a | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 182 | 124 | 5 | a512863304fad80acaab60a8c6107eb7c9cbac99 | |
| Disease | anti-basement membrane glomerulonephritis (biomarker_via_orthology) | 2.52e-04 | 30 | 121 | 3 | DOID:4780 (biomarker_via_orthology) | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 4.84e-04 | 157 | 121 | 5 | DOID:224 (biomarker_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 5.74e-04 | 163 | 121 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 7.35e-04 | 10 | 121 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 7.35e-04 | 10 | 121 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 7.35e-04 | 10 | 121 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 7.35e-04 | 10 | 121 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 7.35e-04 | 10 | 121 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 7.35e-04 | 10 | 121 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 7.35e-04 | 10 | 121 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 7.35e-04 | 10 | 121 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | polymyositis (is_marker_for) | 8.95e-04 | 11 | 121 | 2 | DOID:0080745 (is_marker_for) | |
| Disease | Schizophrenia | RETREG2 MBNL1 PLEKHA6 XRCC1 CMYA5 CCNA2 SNAP29 CDK5R1 PTPRZ1 DGCR8 PICK1 | 1.04e-03 | 883 | 121 | 11 | C0036341 |
| Disease | distal myopathy (implicated_via_orthology) | 1.07e-03 | 12 | 121 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.07e-03 | 12 | 121 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | Alzheimer disease, cognitive decline measurement, Cognitive impairment | 1.26e-03 | 13 | 121 | 2 | EFO_0007710, HP_0100543, MONDO_0004975 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.26e-03 | 13 | 121 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | monokine induced by gamma interferon measurement | 1.28e-03 | 52 | 121 | 3 | EFO_0008236 | |
| Disease | chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology) | 1.47e-03 | 14 | 121 | 2 | DOID:0060413 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 1.69e-03 | 15 | 121 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | prostate carcinoma, type 2 diabetes mellitus | 1.85e-03 | 59 | 121 | 3 | EFO_0001663, MONDO_0005148 | |
| Disease | response to methotrexate | 1.93e-03 | 16 | 121 | 2 | GO_0031427 | |
| Disease | dermatomyositis (is_marker_for) | 2.18e-03 | 17 | 121 | 2 | DOID:10223 (is_marker_for) | |
| Disease | language measurement | 2.29e-03 | 134 | 121 | 4 | EFO_0007797 | |
| Disease | response to ketamine | 2.89e-03 | 69 | 121 | 3 | EFO_0009748 | |
| Disease | Deaf Mutism | 3.02e-03 | 20 | 121 | 2 | C4082305 | |
| Disease | Deafness, Acquired | 3.02e-03 | 20 | 121 | 2 | C0751068 | |
| Disease | Hearing Loss, Extreme | 3.02e-03 | 20 | 121 | 2 | C0086395 | |
| Disease | Complete Hearing Loss | 3.02e-03 | 20 | 121 | 2 | C0581883 | |
| Disease | Prelingual Deafness | 3.02e-03 | 20 | 121 | 2 | C0011052 | |
| Disease | Bilateral Deafness | 3.02e-03 | 20 | 121 | 2 | C3665473 | |
| Disease | myocardial infarction | 3.27e-03 | 350 | 121 | 6 | EFO_0000612 | |
| Disease | Retinitis pigmentosa | 3.53e-03 | 74 | 121 | 3 | cv:C0035334 | |
| Disease | gamma-glutamylglutamine measurement | 3.65e-03 | 22 | 121 | 2 | EFO_0021138 | |
| Disease | Prostatic Neoplasms | 3.95e-03 | 616 | 121 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 3.95e-03 | 616 | 121 | 8 | C0376358 | |
| Disease | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 3.99e-03 | 23 | 121 | 2 | C1708353 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NKYPNLESVNKVNGH | 811 | Q96RT1 | |
| HQLNPATCRNIKKYS | 861 | Q8NEM8 | |
| RKTAPYKNVNIQNFH | 156 | P12814 | |
| KKVQPNSSYQNNITH | 66 | Q15078 | |
| YHLNKLDQNIIPENL | 111 | Q9BXY5 | |
| QLKNNPRHKSYLEQV | 51 | Q96LK0 | |
| NGYTPLHIAAKQNQV | 601 | P16157 | |
| NLPKYVKELHLQENN | 101 | Q9NZU0 | |
| IELQQYAKKNKPNLH | 716 | Q8WYQ5 | |
| KQQLLESPAHQKVRY | 211 | Q5T5Y3 | |
| LSAQQILHVKQEKPY | 521 | O95072 | |
| VNLVPAHKNLNKQAY | 201 | Q9NTI5 | |
| INLIPAHKNLNKQSF | 211 | Q29RF7 | |
| YLQFQDPTKHSRKVN | 671 | Q9Y5F3 | |
| KQEAAAKQHISYQCP | 186 | Q96LL4 | |
| CQQEKKAPLHNLTYE | 206 | Q6P0N0 | |
| NKQHNILTYGNTKPL | 591 | Q96JK9 | |
| HQPVSFYKLKLTNNT | 171 | Q8IWI9 | |
| NTSALPHLYQIKQLQ | 336 | Q12866 | |
| PNAYELIQKIHTLQK | 721 | Q5T655 | |
| PFNSTNKYQLSIHKN | 481 | P05023 | |
| NKYQLSIHKNPNTSE | 486 | P05023 | |
| HVQKLNKFLEPYNDS | 106 | P14415 | |
| PAKYVQDNIQLHGQQ | 621 | Q9UBK8 | |
| LNSPYLHDQKRKEQQ | 576 | Q5T1V6 | |
| QAVYHNVKPAALQQQ | 81 | Q9Y6G5 | |
| NHLKQQLAKEFQAPI | 471 | Q9NVH0 | |
| YHQPNKNQTKLLGTV | 451 | Q9HCI6 | |
| NGESVQIPYNNKLIH | 551 | Q7Z5P9 | |
| NLYQMKSQNPLAKLH | 606 | P35913 | |
| NRTEVYNKLKNCSPH | 276 | Q9Y6X5 | |
| LSQQKQHYNYQTILP | 331 | Q9ULH7 | |
| YEQHLGKSNNFQKPK | 556 | P12882 | |
| NHPDNKHKNRYINIV | 1746 | P23471 | |
| LAQYQNHLQEQPRKA | 166 | Q9BQG0 | |
| LNNPAKHAKLDFLNN | 106 | Q92982 | |
| FPENFHQNLKNLLTK | 86 | Q9P000 | |
| HKNQQAKIAQLYLPF | 1156 | Q5JSL3 | |
| HYIQESICKNPSIKN | 1081 | Q9P2H0 | |
| GKKQQEHQPYSVNVA | 2551 | Q8N3K9 | |
| RYHNLCQKQVKAQLP | 111 | Q9NVF7 | |
| NIAKHYKNNPSLITF | 891 | Q9BYX4 | |
| AHLQAKIKAAQYQVN | 241 | Q9NR56 | |
| PLYLNIALLKHNQEQ | 256 | A6NNW6 | |
| PLAIVNKAHQANQLY | 761 | Q14204 | |
| PFQYQLVIKNHKQLS | 96 | O75881 | |
| PKQHQQSPKQQLYQV | 401 | Q7Z589 | |
| SQQYEVNKSNYKLPH | 461 | Q9NRM1 | |
| APQHAQQSIREKYKN | 401 | P20248 | |
| NEKTNNGIHYKLQLL | 101 | Q9H4W6 | |
| YKQHKTDLEAIPQQC | 81 | A4D161 | |
| YTHNPSQAEKLQKDL | 896 | O95487 | |
| APNHYQVVKDGLNQK | 466 | P46059 | |
| KKYNPGHLLQTNEQF | 56 | Q7Z7J5 | |
| LIHNYKKNPNFNTLV | 1171 | Q9HC10 | |
| SQPKGLQKTDLYHLQ | 516 | Q9UBD5 | |
| ELKALHLVPQYQDQN | 231 | Q9Y4I5 | |
| HQDKNLVVINKPYGL | 101 | Q96CM3 | |
| EQFYLQALKLPNQTH | 161 | Q9NP81 | |
| YNLLKIQLGKDNQHQ | 701 | O60763 | |
| EIYKKLVNSQQVPNH | 131 | Q2M5E4 | |
| PYQNIKILHSKQFGN | 146 | P52788 | |
| LTKQHPSVSLQQYKN | 716 | Q6YHU6 | |
| QLQQLKHLESFYEKP | 41 | Q8TA86 | |
| NHIILNQGNIFKKYS | 51 | Q96DL1 | |
| TYLPNSTKKIQFHQE | 356 | Q8IV36 | |
| KIANNSYACKHPEVQ | 41 | O00141 | |
| HLQELLQYKRQNPAQ | 171 | Q8NC44 | |
| HCFLNKSQAPKNYQV | 121 | A8MTI9 | |
| QEAKYQASHPNLRKL | 156 | O95721 | |
| FANLKHYQKQQSLPS | 1451 | Q8TF72 | |
| PLLYEKNLVKHLNQG | 371 | P15907 | |
| YEQHLGKSNNFQKPK | 556 | Q9Y623 | |
| NHYKSNVEIFKLQPN | 36 | Q9NVU7 | |
| HQALQGAYLKNNLPV | 1786 | Q9P2P6 | |
| KYDANQQARKHLLPV | 336 | Q96K37 | |
| ACEKLPKANHNNIRY | 366 | Q17R89 | |
| PKANHNNIRYLIKFL | 371 | Q17R89 | |
| QKHKQLYPSCSFIQN | 101 | Q13490 | |
| LTNQIECHPYLTQKN | 191 | Q96JD6 | |
| QTQQKKYLEQLHLPQ | 2511 | A4UGR9 | |
| KANYEQSKKDPHQTL | 726 | Q9Y2H5 | |
| NQHQRIQTGEKPYKC | 376 | Q9P2J8 | |
| VHPVLEKLKAINNYN | 391 | Q7Z739 | |
| VQHPNKGLQLLLKYT | 56 | A0A0B4J237 | |
| YDQSHARNKPIKDQL | 126 | Q86XN6 | |
| QRIPQSQKDHYKSQA | 266 | P0CB48 | |
| YCNINPHHSKQLKLN | 111 | Q96MF0 | |
| NIHIQKKPYNSNECG | 201 | Q8TB69 | |
| PVKYHLQNKTDLVQD | 1031 | Q7Z392 | |
| PTKYHIQQAQRQQVK | 126 | O75030 | |
| QTPQNEHIYQQKNKL | 571 | Q13905 | |
| QEYLQKLLQHPELSN | 661 | Q9Y5W7 | |
| NLQSIPKKTQHYFLL | 1156 | Q12767 | |
| ETKAHQILQQKPAQY | 656 | O75038 | |
| NYKDPTNLQGKLQKH | 71 | Q13813 | |
| YKDPSNLQGKVQKHQ | 601 | Q13813 | |
| PQLIDYSRNKNVKNH | 961 | Q9BX26 | |
| IKENHKNIPLALNYI | 581 | Q96K83 | |
| QYNQIRSLHPKTFEK | 91 | Q7L0X0 | |
| LKVEPNNYLSINLHQ | 446 | Q9HBJ7 | |
| AQHQKIHTGQKPYNN | 271 | Q76KX8 | |
| LEQKINNYLTVPAHK | 676 | P19634 | |
| KTKSQYHDLQAPDNQ | 126 | Q9H788 | |
| NQKLNKIPEHIPQYT | 521 | O94813 | |
| PHTQYQFSVLAQNKL | 576 | Q9P2J2 | |
| YQNKQKLRKQHSDPV | 536 | Q8IYT8 | |
| NEKQKLLPHQLYGVV | 616 | P18887 | |
| QLSQHQKIHNGEKPY | 321 | Q8TAQ5 | |
| AYELHQENKKPTSQR | 946 | Q9UI33 | |
| QNHKITQLKIENNPF | 231 | P57082 | |
| SQKKAEAQPVHQAYQ | 711 | Q9UQR1 | |
| PKNKENIIYLANHQS | 81 | Q9NUQ2 | |
| VNPINANNHYDKILA | 16 | Q15063 | |
| EVTIHYNKLQADPKQ | 96 | Q9NRD5 | |
| SKNIQQSNHLPKYER | 426 | Q8IWU6 | |
| NFPHYQQLQKNCLLS | 436 | Q6WRX3 | |
| IQHQKIHTNEKPYQC | 211 | Q7Z3V5 | |
| HFQTLLQKALEKQNP | 691 | Q9UPU7 | |
| PHEQKIKLYQDQLQK | 146 | O14657 | |
| SKIPVALLIHYQQNQ | 41 | P78423 | |
| QQPNQKFHLSYTDKE | 81 | Q96MV8 | |
| YHKENLQKLPQLAAI | 526 | O43264 | |
| EDFQKKNNLYPHRTA | 461 | Q9C0D4 | |
| QQEKHKQNFAPFNVL | 101 | Q8TCI5 | |
| QNPYHQQALAEKVKE | 281 | P57678 | |
| YVPQLLKEEKASHQQ | 51 | Q13508 | |
| LKVGLKPEANKQYHN | 2631 | Q9NR99 | |
| KPEANKQYHNLVSII | 2636 | Q9NR99 | |
| HKLNSQHKLNANYIP | 526 | Q13402 | |
| QHKLNANYIPPKNNH | 531 | Q13402 |